Four Key Areas Shaping the Chinese Pharma Industry
[/color][/size]
For the majority of traditional pharma companies, 2017 was a tough year. A round of new policies repeatedly challenged and changed the industry status quo. For innovative pharmas, however, it was a different story – a year full of hopes and opportunities.
Thanks to the steady increase in healthcare need, the introduction of policies favorable to innovation, and capital injections, the Chinese pharma industry could be entering a golden age of innovation and development. In this ever-changing market, where will the industry go now?
Source : http://www.pharmexec.com/four-key-areas-shaping-chinese-pharma-industry